Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

NIH 1

Study Type

Interventional 11Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia 1

Interventions

Surveys and Questionnaires 13Blood Specimen Collection 13Specimen Handling 10Magnetic Resonance Spectroscopy 5Surgical Procedures, Operative 4Radiotherapy 4Observation 4Data Collection 4ribociclib 3darolutamide 3Watchful Waiting 3Standard of Care 3Patient Reported Outcome Measures 3Mental Status and Dementia Tests 3Interviews as Topic 3Immune Checkpoint Inhibitors 3Hepatectomy 3Breath Tests 3Biopsy 3trastuzumab deruxtecan 2palbociclib 2atezolizumab 2X-Rays 2Ultrasonography 2Tomography, X-Ray Computed 2Sulfonylurea Compounds 2Restraint, Physical 2Neoadjuvant Therapy 2Methods 2Mass Screening 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Leukapheresis × 30 days × Clear all
NCT03226704 2026-05-20

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
120 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡